Shire not switching fill finish supplier responsible for VPRIV recall
Shire has recalled one batch of its Gaucher’s disease drug VPRIV in the US after problems at its fill finish contractor resulted in particulate matter ending up in the vials.
Archives for March 18, 2014
Hospira edges closer to completion of Orchid API deal in India
The Board of Directors at Indian firm Orchid has approved the sale of its API business to Hospira, bringing the acquisition a step closer to completion.
Novo Nordisk buys rights to Caisson’s drug-extending biotech
Caisson Biotech has licensed its drug-extending technology for injectables to Novo Nordisk.
Industry worried "genetic resources" rules will slow flu vaccine production
New EU laws safeguarding national ownership of ‘genetic resources’ may delay production of seasonal influenza vaccines according to EFPIA, which wants stakeholders to discuss the issue.